153 related articles for article (PubMed ID: 38522060)
21. Identification of BIK as an unfavorable prognostic marker and novel therapeutic target in microsatellite stable colorectal cancer harboring KRAS mutations.
Liu P; Jiao F; Zhang Z; Zhao F; Cai J; Chen S; Fu T; Li M
Am J Cancer Res; 2022; 12(11):5300-5314. PubMed ID: 36504908
[No Abstract] [Full Text] [Related]
22. Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients.
Shioiri M; Shida T; Koda K; Oda K; Seike K; Nishimura M; Takano S; Miyazaki M
Br J Cancer; 2006 Jun; 94(12):1816-22. PubMed ID: 16773075
[TBL] [Abstract][Full Text] [Related]
23. Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer.
Reggiani Bonetti L; Barresi V; Maiorana A; Manfredini S; Caprera C; Bettelli S
Dis Markers; 2018; 2018():2959801. PubMed ID: 30018674
[TBL] [Abstract][Full Text] [Related]
24. Genomic nursing science revealed the prolyl 4-hydroxylase subunit alpha 2 as a significant biomarker involved in osteosarcoma.
Chen HP; Han X; Sun HP; Xie T; Fan XL
Heliyon; 2024 Mar; 10(5):e27191. PubMed ID: 38468936
[TBL] [Abstract][Full Text] [Related]
25. Impact of sidedness of colorectal cancer on tumor immunity.
Takasu C; Nishi M; Yoshikawa K; Tokunaga T; Kashihara H; Yoshimoto T; Shimada M
PLoS One; 2020; 15(10):e0240408. PubMed ID: 33045001
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of HHLA2 and CD8 Immunohistochemical Expression in Colorectal Carcinoma and Their Prognostic Significance.
Gawesh ZM; Ibrahim EM; ElKalla HMHR; Awad AAH; Mohamed MA
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4309-4319. PubMed ID: 38156868
[TBL] [Abstract][Full Text] [Related]
27. High MEIS3 Expression Indicates a Poor Prognosis for Patients with Stage II/III Colorectal Cancer.
Ma J; Li H; Gao Q; Zhang W; Zhu C; Chen J; Ling Y; Shao X; Li Z
Front Biosci (Landmark Ed); 2023 Dec; 28(12):338. PubMed ID: 38179750
[TBL] [Abstract][Full Text] [Related]
28. Novel applications of histopathological markers to distinguish prognostic subgroups in colorectal adenocarcinoma.
Yuan Y; Ren W; Zhu J; Ji S; Yang Q
Ann Med; 2023; 55(2):2244181. PubMed ID: 37557892
[TBL] [Abstract][Full Text] [Related]
29. YAP promotes epithelial mesenchymal transition by upregulating Slug expression in human colorectal cancer cells.
Cheng D; Jin L; Chen Y; Xi X; Guo Y
Int J Clin Exp Pathol; 2020; 13(4):701-710. PubMed ID: 32355518
[TBL] [Abstract][Full Text] [Related]
30. Angiopoietin-like protein 1 inhibits epithelial to mesenchymal transition in colorectal cancer cells via suppress Slug expression.
Fan H; Huang L; Zhuang X; Ai F; Sun W
Cytotechnology; 2019 Feb; 71(1):35-44. PubMed ID: 30610511
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
[TBL] [Abstract][Full Text] [Related]
32. Clinico-pathological evaluation of tumor budding in the oncological progression of colorectal cancer.
Giordano PG; Díaz Zelaya AG; Aguilera Molina YY; Taboada Mostajo NO; Ajete Ramos Y; Ortega García R; Peralta de Michelis E; Meneu Díaz JC
Med Clin (Barc); 2024 May; ():. PubMed ID: 38697893
[TBL] [Abstract][Full Text] [Related]
33. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
[No Abstract] [Full Text] [Related]
34. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
[TBL] [Abstract][Full Text] [Related]
35. The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.
Huang CW; Tsai HL; Chen YT; Huang CM; Ma CJ; Lu CY; Kuo CH; Wu DC; Chai CY; Wang JY
BMC Cancer; 2013 Dec; 13():599. PubMed ID: 24330663
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer.
Ma Z; Lian J; Yang M; Wuyang J; Zhao C; Chen W; Liu C; Zhao Q; Lou C; Han J; Zhang Y
Pathol Res Pract; 2019 Jun; 215(6):152383. PubMed ID: 30890279
[TBL] [Abstract][Full Text] [Related]
37. Expression of BTBD7 in primary salivary adenoid cystic carcinoma and correlation with Slug and prognosis.
Yang L; Wang T; Zhang J; Liu Z; Wang X
Cancer Biomark; 2016 Jun; 17(2):179-85. PubMed ID: 27540976
[TBL] [Abstract][Full Text] [Related]
38. Tumor budding and human chorionic gonadotropin-β expression correlate with unfavorable patient outcome in colorectal carcinoma.
Konishi Y; Kawamata F; Nishihara H; Homma S; Kato Y; Tsuda M; Kohsaka S; Einama T; Liu C; Yoshida T; Nagatsu A; Tanino M; Tanaka S; Kawamura H; Kamiyama T; Taketomi A
Med Oncol; 2018 Jun; 35(7):104. PubMed ID: 29892782
[TBL] [Abstract][Full Text] [Related]
39. The epithelial-mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients.
Børretzen A; Gravdal K; Haukaas SA; Mannelqvist M; Beisland C; Akslen LA; Halvorsen OJ
J Pathol Clin Res; 2021 May; 7(3):253-270. PubMed ID: 33605548
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and clinicopathological value of Slug protein expression in breast cancer: a systematic review and meta-analysis.
Zhang Z; Fang T; Lv Y
World J Surg Oncol; 2022 Nov; 20(1):361. PubMed ID: 36372891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
